NCT01895101View on ClinicalTrials.gov

The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Blood LossTranexamic AcidCardiac Surgery
Interventions
DRUG

2 gr tranexamic acid

This group receives pericardial lavage with 2 gr tranexamic diluted in 200 ml normothermic saline solution (NaCl 0.9%).

DRUG

Saline

This group receives pericardial lavage with 200 ml normothermic saline solution without tranexamic acid

Trial Locations (1)

4800 RK

Amphia Hospital, Breda

All Listed Sponsors
lead

Amphia Hospital

OTHER

NCT01895101 - The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients | Biotech Hunter | Biotech Hunter